Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Aerovate Therapeutics Inc.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-09-12
Sale
2022-09-14
5:15 pm
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
SEE REMARKS
7,520 $17.33 $130,307 36,900
(Direct)
View
2022-09-08
Sale
2022-09-12
5:30 pm
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks
7,840 $17.8 $139,584 108,310
(Direct)
View
2022-09-06
Sale
2022-09-08
5:30 pm
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks
12,829 $18.5 $237,345 82,476
(Direct)
View
2022-09-06
Sale
2022-09-07
5:30 pm
Aerovate Therapeutics Inc. AVTE NIVEN RALPH
Chief Scientific Officer
2,250 $19 $42,750 161,639
(Direct)
View
2022-08-18
Sale
2022-08-19
5:00 pm
Aerovate Therapeutics Inc. AVTE NIVEN RALPH
Chief Scientific Officer
2,250 $21.18 $47,657 163,889
(Direct)
View
2022-08-16
Sale
2022-08-18
5:00 pm
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks
21,000 $23 $482,932 69,908
(Direct)
View
2022-08-10
Sale
2022-08-12
5:15 pm
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks
14,067 $24.07 $338,598 38,513
(Direct)
View
2022-08-08
Sale
2022-08-10
5:15 pm
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks
15,643 $24.31 $380,287 74,000
(Direct)
View
2021-07-02
Purchase
2021-07-07
4:45 pm
Aerovate Therapeutics Inc. AVTE Cormorant Asset Management LP
Chen Bihua
Cormorant Global Healthcare Master Fund LP
Cormorant Private Healthcare Fund II LP
Former 10% Owner
500,000 $14 $7,000,000 2,030,691
(Indirect)
View
2021-07-02
Purchase
2021-07-06
5:03 pm
Aerovate Therapeutics Inc. AVTE RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
2,785,714 $14 $38,999,996 311,170
(Indirect)
View
2021-07-02
Purchase
2021-07-06
4:28 pm
Aerovate Therapeutics Inc. AVTE Sofinnova Venture Partners X L.P.
Sofinnova Management X L.L.C.
HEALY JAMES
10% Owner
357,142 $14 $4,999,988 3,758,686
(Direct)
View
2021-07-01
Purchase
2021-07-06
4:27 pm
Aerovate Therapeutics Inc. AVTE Katabi Maha
Director
10% Owner
357,142 $14 $4,999,988 3,761,153
(Indirect
Direct)
View
2021-07-01
Purchase
2021-07-06
4:27 pm
Aerovate Therapeutics Inc. AVTE GRAYZEL DAVID S.
Director
535,714 $14 $7,499,996 3,106,032
(Indirect
Direct)
View
2021-07-02
Purchase
2021-07-06
4:26 pm
Aerovate Therapeutics Inc. AVTE Atlas Venture Fund XII L.P.
Atlas Venture Associates XII L.P.
Atlas Venture Associates XII LLC
10% Owner
535,714 $14 $7,499,996 3,103,879
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-09-12
Exercise
2022-09-14
5:15 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
SEE REMARKS
7,520 $2.14 36,900
(Direct)
View
2022-09-12
Exercise
2022-09-14
5:15 pm
N/A
2031-04-02
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
SEE REMARKS
7,520 $0 36,900
(Direct)
View
2022-09-08
Exercise
2022-09-12
5:30 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks
4,462 $2.14 108,310
(Direct)
View
2022-09-08
Exercise
2022-09-12
5:30 pm
N/A
2030-09-03
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks
7,840 $0 108,310
(Direct)
View
2022-09-08
Exercise
2022-09-12
5:30 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks
3,378 $1.74 108,310
(Direct)
View
2022-09-06
Exercise
2022-09-08
5:30 pm
N/A
2030-09-03
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks
17,386 $0 82,476
(Direct)
View
2022-09-06
Exercise
2022-09-08
5:30 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks
17,386 $1.74 82,476
(Direct)
View
2022-09-06
Exercise
2022-09-07
5:30 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE NIVEN RALPH
Chief Scientific Officer
1,600 $2.14 161,639
(Direct)
View
2022-09-06
Exercise
2022-09-07
5:30 pm
N/A
2030-09-03
Aerovate Therapeutics Inc. AVTE NIVEN RALPH
Chief Scientific Officer
2,250 $0 161,639
(Direct)
View
2022-09-06
Exercise
2022-09-07
5:30 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE NIVEN RALPH
Chief Scientific Officer
650 $1.74 161,639
(Direct)
View
2022-08-18
Exercise
2022-08-19
5:00 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE NIVEN RALPH
Chief Scientific Officer
1,600 $2.14 163,889
(Direct)
View
2022-08-18
Exercise
2022-08-19
5:00 pm
N/A
2030-09-03
Aerovate Therapeutics Inc. AVTE NIVEN RALPH
Chief Scientific Officer
2,250 $0 163,889
(Direct)
View
2022-08-18
Exercise
2022-08-19
5:00 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE NIVEN RALPH
Chief Scientific Officer
650 $1.74 163,889
(Direct)
View
2022-08-16
Exercise
2022-08-18
5:00 pm
N/A
2030-09-03
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks
21,000 $0 69,908
(Direct)
View
2022-08-16
Exercise
2022-08-18
5:00 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks
21,000 $1.74 69,908
(Direct)
View
2022-08-10
Exercise
2022-08-12
5:15 pm
N/A
2030-09-03
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks
14,067 $0 38,513
(Direct)
View
2022-08-10
Exercise
2022-08-12
5:15 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks
14,067 $1.74 38,513
(Direct)
View
2022-08-08
Exercise
2022-08-10
5:15 pm
N/A
2030-09-03
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks
15,643 $0 74,000
(Direct)
View
2022-08-08
Exercise
2022-08-10
5:15 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks
15,643 $1.74 74,000
(Direct)
View
2022-07-15
Other
2022-07-19
5:28 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Atlas Venture Fund XII L.P.
10% Owner
310,388 $0 2,638,297
(Direct)
View
2022-06-21
Option Award
2022-06-22
5:01 pm
N/A
2032-06-20
Aerovate Therapeutics Inc. AVTE Dorval Allison
Director
12,500 $0 12,500
(Direct)
View
2022-06-21
Option Award
2022-06-22
5:00 pm
N/A
2032-06-20
Aerovate Therapeutics Inc. AVTE Iwicki Mark T
Director
12,500 $0 12,500
(Direct)
View
2022-06-21
Option Award
2022-06-22
5:00 pm
N/A
2032-06-20
Aerovate Therapeutics Inc. AVTE Resnick Joshua
Director
12,500 $0 12,500
(Direct)
View
2022-06-21
Option Award
2022-06-22
5:00 pm
N/A
2032-06-20
Aerovate Therapeutics Inc. AVTE RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
12,500 $0 12,500
(Indirect)
View
2022-06-21
Option Award
2022-06-22
5:00 pm
N/A
2032-06-20
Aerovate Therapeutics Inc. AVTE GRAYZEL DAVID S.
Director
12,500 $0 12,500
(Direct)
View
2022-06-21
Option Award
2022-06-22
5:00 pm
N/A
2032-06-20
Aerovate Therapeutics Inc. AVTE Katabi Maha
Director
10% Owner
12,500 $0 12,500
(Direct)
View
2022-04-01
Other
2022-04-04
5:13 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Atlas Venture Fund XII L.P.
10% Owner
465,582 $0 3,103,879
(Direct)
View
2022-03-21
Option Award
2022-03-23
07:47 am
N/A
2032-03-20
Aerovate Therapeutics Inc. AVTE Verwijs Marinus
VP
90,000 $0 90,000
(Direct)
View
2022-01-03
Option Award
2022-01-05
5:15 pm
N/A
2032-01-02
Aerovate Therapeutics Inc. AVTE GRAYZEL DAVID S.
Director
7,317 $6.56 7,317
(Direct)
View
2022-01-03
Option Award
2022-01-05
5:15 pm
N/A
2032-01-02
Aerovate Therapeutics Inc. AVTE Katabi Maha
Director
10% Owner
7,240 $6.56 7,240
(Direct)
View
2021-12-14
Option Award
2021-12-16
6:00 pm
N/A
2031-12-13
Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks
58,000 $0 58,000
(Direct)
View
2021-12-14
Option Award
2021-12-16
6:00 pm
N/A
2031-12-13
Aerovate Therapeutics Inc. AVTE NOYES TIMOTHY P
CEO
204,501 $0 204,501
(Direct)
View
2021-12-14
Option Award
2021-12-16
6:00 pm
N/A
2031-12-13
Aerovate Therapeutics Inc. AVTE Gillies Hunter
Chief Medical Officer
65,433 $0 65,433
(Direct)
View
2021-12-14
Option Award
2021-12-16
6:00 pm
N/A
2031-12-13
Aerovate Therapeutics Inc. AVTE Eldridge George A
See Remarks
65,433 $0 65,433
(Direct)
View
2021-12-14
Option Award
2021-12-16
6:00 pm
N/A
2031-12-13
Aerovate Therapeutics Inc. AVTE NIVEN RALPH
Chief Development Officer
65,433 $0 65,433
(Direct)
View
2021-07-15
Option Award
2021-07-19
4:28 pm
N/A
2031-07-14
Aerovate Therapeutics Inc. AVTE Dorval Allison
Director
25,000 $0 25,000
(Direct)
View
2021-07-02
Conversion
2021-07-07
4:45 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Cormorant Asset Management LP
Chen Bihua
Cormorant Global Healthcare Master Fund LP
Cormorant Private Healthcare Fund II LP
Former 10% Owner
1,530,691 $0 2,030,691
(Indirect)
View
2021-07-02
Conversion
2021-07-06
5:03 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
21,502,383 $0 311,170
(Indirect)
View
2021-07-02
Conversion
2021-07-06
4:28 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Sofinnova Venture Partners X L.P.
Sofinnova Management X L.L.C.
HEALY JAMES
10% Owner
13,966,782 $0 3,758,686
(Direct)
View
2021-07-01
Conversion
2021-07-06
4:27 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Katabi Maha
Director
10% Owner
13,966,782 $0 3,761,153
(Indirect)
View
2021-07-01
Option Award
2021-07-06
4:27 pm
N/A
2031-06-30
Aerovate Therapeutics Inc. AVTE Katabi Maha
Director
10% Owner
2,467 $11.15 3,761,153
(Direct)
View
2021-07-01
Conversion
2021-07-06
4:27 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE GRAYZEL DAVID S.
Director
10,544,919 $0 3,106,032
(Indirect)
View
2021-07-01
Option Award
2021-07-06
4:27 pm
N/A
2031-06-30
Aerovate Therapeutics Inc. AVTE GRAYZEL DAVID S.
Director
2,153 $11.15 3,106,032
(Direct)
View
2021-07-02
Conversion
2021-07-06
4:26 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Atlas Venture Fund XII L.P.
Atlas Venture Associates XII L.P.
Atlas Venture Associates XII LLC
10% Owner
10,544,919 $0 3,103,879
(Direct)
View
2021-06-29
Option Award
2021-07-01
6:36 pm
N/A
2031-06-28
Aerovate Therapeutics Inc. AVTE Resnick Joshua
Director
25,000 $0 25,000
(Direct)
View
2021-04-02
Option Award
2021-07-01
6:35 pm
N/A
2031-04-01
Aerovate Therapeutics Inc. AVTE NIVEN RALPH
Chief Development Officer
152,234 $0 152,234
(Direct)
View
2021-02-01
Option Award
2021-07-01
6:34 pm
N/A
2031-06-28
Aerovate Therapeutics Inc. AVTE Katabi Maha
Director
10% Owner
25,000 $0 13,073,286
(Direct)
View
2021-02-01
Option Award
2021-07-01
6:34 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE Katabi Maha
Director
10% Owner
9,246,403 $1.893 13,073,286
(Indirect)
View
2021-04-02
Option Award
2021-07-01
6:33 pm
N/A
2031-04-01
Aerovate Therapeutics Inc. AVTE Iwicki Mark T
Director
158,497 $0 158,497
(Direct)
View
2021-02-01
Option Award
2021-07-01
6:32 pm
N/A
2031-06-28
Aerovate Therapeutics Inc. AVTE GRAYZEL DAVID S.
Director
25,000 $0 9,876,456
(Direct)
View
2021-02-01
Option Award
2021-07-01
6:32 pm
N/A
N/A
Aerovate Therapeutics Inc. AVTE GRAYZEL DAVID S.
Director
6,981,033 $1.893 9,876,456
(Indirect)
View
2021-04-02
Option Award
2021-07-01
6:32 pm
N/A
2031-04-01
Aerovate Therapeutics Inc. AVTE NOYES TIMOTHY P
CEO
1,018,834 $0 1,018,834
(Direct)
View
2021-04-02
Option Award
2021-07-01
6:31 pm
N/A
2031-04-01
Aerovate Therapeutics Inc. AVTE Gillies Hunter
Chief Medical Officer
186,234 $0 186,234
(Direct)
View
Goto 0, 1, Next